Kristin Elyse Burke, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colitis, Microscopic | 10 | 2023 | 71 | 3.250 |
Why?
|
Colitis, Ulcerative | 20 | 2024 | 1926 | 2.440 |
Why?
|
Crohn Disease | 15 | 2024 | 2295 | 1.810 |
Why?
|
Colitis, Collagenous | 3 | 2023 | 25 | 1.650 |
Why?
|
Inflammatory Bowel Diseases | 15 | 2024 | 2442 | 1.570 |
Why?
|
Colitis, Lymphocytic | 2 | 2021 | 23 | 0.790 |
Why?
|
Adenomatous Polyps | 1 | 2019 | 109 | 0.610 |
Why?
|
Physician Assistants | 1 | 2020 | 190 | 0.600 |
Why?
|
Professional Role | 1 | 2020 | 316 | 0.580 |
Why?
|
Pyoderma Gangrenosum | 1 | 2019 | 84 | 0.580 |
Why?
|
Nurse Practitioners | 1 | 2020 | 271 | 0.570 |
Why?
|
Contraceptives, Oral | 1 | 2018 | 560 | 0.510 |
Why?
|
Obstetric Labor Complications | 1 | 2017 | 244 | 0.470 |
Why?
|
Colonic Polyps | 1 | 2019 | 557 | 0.460 |
Why?
|
Bronchial Neoplasms | 1 | 2014 | 110 | 0.450 |
Why?
|
Gastroenterology | 1 | 2020 | 593 | 0.450 |
Why?
|
Feces | 3 | 2024 | 1511 | 0.440 |
Why?
|
Gastrointestinal Agents | 1 | 2018 | 511 | 0.430 |
Why?
|
Colonoscopy | 2 | 2021 | 1409 | 0.400 |
Why?
|
Estrogen Replacement Therapy | 1 | 2018 | 1209 | 0.390 |
Why?
|
Biological Products | 1 | 2021 | 948 | 0.370 |
Why?
|
Metagenome | 2 | 2024 | 465 | 0.370 |
Why?
|
Transplants | 1 | 2013 | 208 | 0.360 |
Why?
|
Environment | 1 | 2017 | 1121 | 0.360 |
Why?
|
Delivery, Obstetric | 1 | 2017 | 954 | 0.340 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2013 | 327 | 0.330 |
Why?
|
Guideline Adherence | 1 | 2019 | 2235 | 0.320 |
Why?
|
Cesarean Section | 1 | 2017 | 1425 | 0.300 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4206 | 0.290 |
Why?
|
Smoking | 4 | 2022 | 9092 | 0.290 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4352 | 0.270 |
Why?
|
Clostridium Infections | 1 | 2014 | 562 | 0.270 |
Why?
|
Incidence | 13 | 2024 | 21538 | 0.260 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2018 | 2333 | 0.260 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3239 | 0.240 |
Why?
|
Risk Factors | 20 | 2024 | 74944 | 0.220 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1960 | 0.220 |
Why?
|
Budesonide | 2 | 2021 | 162 | 0.220 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5520 | 0.210 |
Why?
|
Prospective Studies | 18 | 2023 | 54926 | 0.210 |
Why?
|
Cyclopentanes | 2 | 2015 | 87 | 0.200 |
Why?
|
Liver Neoplasms | 2 | 2018 | 4362 | 0.200 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7454 | 0.190 |
Why?
|
Celiac Disease | 2 | 2021 | 820 | 0.190 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6395 | 0.190 |
Why?
|
Tooth Loss | 1 | 2023 | 200 | 0.190 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2024 | 301 | 0.180 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2023 | 296 | 0.180 |
Why?
|
Colorectal Neoplasms | 2 | 2021 | 6974 | 0.180 |
Why?
|
Proportional Hazards Models | 6 | 2024 | 12543 | 0.170 |
Why?
|
Glutens | 2 | 2021 | 240 | 0.170 |
Why?
|
Health Surveys | 3 | 2018 | 4057 | 0.170 |
Why?
|
Periodontal Diseases | 1 | 2023 | 455 | 0.170 |
Why?
|
Humans | 44 | 2024 | 768166 | 0.160 |
Why?
|
Pyrimidines | 3 | 2019 | 3048 | 0.150 |
Why?
|
Models, Organizational | 1 | 2020 | 548 | 0.140 |
Why?
|
Reproductive History | 1 | 2018 | 210 | 0.140 |
Why?
|
Odds Ratio | 2 | 2021 | 9669 | 0.140 |
Why?
|
Viral Vaccines | 1 | 2022 | 596 | 0.130 |
Why?
|
Diet Surveys | 1 | 2020 | 1160 | 0.130 |
Why?
|
Fluorocarbons | 1 | 2021 | 506 | 0.130 |
Why?
|
Follow-Up Studies | 11 | 2023 | 39348 | 0.130 |
Why?
|
Adult | 15 | 2024 | 223646 | 0.120 |
Why?
|
Androgens | 1 | 2022 | 1281 | 0.120 |
Why?
|
Diarrhea | 1 | 2021 | 1320 | 0.120 |
Why?
|
Middle Aged | 15 | 2024 | 223492 | 0.120 |
Why?
|
Genotype | 3 | 2024 | 13045 | 0.110 |
Why?
|
Female | 20 | 2024 | 397192 | 0.110 |
Why?
|
Aged | 12 | 2022 | 171504 | 0.110 |
Why?
|
Ubiquitin-Activating Enzymes | 2 | 2015 | 85 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 951 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2022 | 4045 | 0.100 |
Why?
|
Pyrroles | 1 | 2019 | 1124 | 0.100 |
Why?
|
Asia | 1 | 2014 | 629 | 0.100 |
Why?
|
Genetic Markers | 1 | 2018 | 2603 | 0.100 |
Why?
|
Nurses | 1 | 2021 | 2501 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1596 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1805 | 0.090 |
Why?
|
Regression Analysis | 1 | 2021 | 6340 | 0.090 |
Why?
|
Enteral Nutrition | 1 | 2017 | 802 | 0.090 |
Why?
|
Feeding Behavior | 2 | 2020 | 3205 | 0.090 |
Why?
|
Quality of Life | 2 | 2023 | 13490 | 0.090 |
Why?
|
Colitis | 1 | 2019 | 1242 | 0.090 |
Why?
|
ROC Curve | 1 | 2018 | 3628 | 0.090 |
Why?
|
Menopause | 1 | 2018 | 1656 | 0.090 |
Why?
|
North America | 1 | 2014 | 1289 | 0.090 |
Why?
|
Piperidines | 1 | 2019 | 1667 | 0.090 |
Why?
|
Intestinal Mucosa | 3 | 2020 | 3044 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2014 | 1836 | 0.080 |
Why?
|
Waiting Lists | 1 | 2014 | 779 | 0.080 |
Why?
|
Virulence | 1 | 2013 | 1297 | 0.080 |
Why?
|
Male | 13 | 2023 | 364719 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1805 | 0.080 |
Why?
|
Biopsy, Needle | 1 | 2014 | 1622 | 0.080 |
Why?
|
Young Adult | 4 | 2021 | 60066 | 0.080 |
Why?
|
Time Factors | 3 | 2021 | 40218 | 0.080 |
Why?
|
Bronchoscopy | 1 | 2014 | 914 | 0.080 |
Why?
|
Weight Gain | 1 | 2018 | 2359 | 0.080 |
Why?
|
Integrins | 1 | 2012 | 842 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2021 | 59629 | 0.070 |
Why?
|
United States | 6 | 2024 | 73039 | 0.070 |
Why?
|
Treatment Failure | 1 | 2013 | 2661 | 0.070 |
Why?
|
Europe | 1 | 2014 | 3436 | 0.070 |
Why?
|
Sweden | 2 | 2020 | 1382 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2018 | 2085 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2012 | 840 | 0.060 |
Why?
|
Respiratory Insufficiency | 1 | 2014 | 1240 | 0.060 |
Why?
|
Registries | 2 | 2020 | 8375 | 0.060 |
Why?
|
Receptors, Prostaglandin | 1 | 2005 | 53 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9374 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3591 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12077 | 0.060 |
Why?
|
Clinical Competence | 1 | 2020 | 4858 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2017 | 3445 | 0.060 |
Why?
|
Leukocytes | 1 | 2012 | 2035 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 8080 | 0.050 |
Why?
|
Logistic Models | 1 | 2018 | 13290 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2018 | 12800 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2021 | 81762 | 0.050 |
Why?
|
Diet | 2 | 2021 | 8089 | 0.050 |
Why?
|
Adolescent | 3 | 2021 | 89169 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15454 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26379 | 0.050 |
Why?
|
MicroRNAs | 1 | 2018 | 3803 | 0.050 |
Why?
|
Liver Transplantation | 1 | 2014 | 2401 | 0.050 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2022 | 241 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2017 | 4530 | 0.050 |
Why?
|
Self Report | 2 | 2024 | 3773 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11095 | 0.040 |
Why?
|
Recurrence | 1 | 2013 | 8509 | 0.040 |
Why?
|
Cohort Studies | 5 | 2022 | 41754 | 0.040 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2022 | 553 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13676 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 622 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2022 | 22291 | 0.040 |
Why?
|
Cholangitis, Sclerosing | 1 | 2021 | 179 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 13014 | 0.040 |
Why?
|
Receptors, Immunologic | 1 | 2005 | 1418 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 16045 | 0.040 |
Why?
|
Biopsy | 2 | 2021 | 6793 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 30010 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3728 | 0.040 |
Why?
|
Hyperplasia | 1 | 2021 | 1151 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2021 | 65371 | 0.040 |
Why?
|
Disease Progression | 1 | 2014 | 13671 | 0.040 |
Why?
|
Phylogeny | 1 | 2024 | 2843 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 13090 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2013 | 10399 | 0.030 |
Why?
|
Child Abuse | 1 | 2024 | 1091 | 0.030 |
Why?
|
Caspases | 1 | 2018 | 882 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 1951 | 0.030 |
Why?
|
Pregnancy | 1 | 2017 | 30256 | 0.030 |
Why?
|
Neoplasms | 2 | 2015 | 22371 | 0.030 |
Why?
|
Bacteria | 1 | 2024 | 2216 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 1151 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2021 | 4860 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2015 | 899 | 0.030 |
Why?
|
HeLa Cells | 1 | 2018 | 3074 | 0.020 |
Why?
|
Prevalence | 2 | 2020 | 15869 | 0.020 |
Why?
|
Consensus | 1 | 2022 | 3212 | 0.020 |
Why?
|
Colon | 1 | 2020 | 1801 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6082 | 0.020 |
Why?
|
Testosterone | 1 | 2022 | 2491 | 0.020 |
Why?
|
Hepatocytes | 1 | 2018 | 1247 | 0.020 |
Why?
|
Life Style | 1 | 2022 | 3932 | 0.020 |
Why?
|
Macaca fascicularis | 1 | 2012 | 912 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1906 | 0.020 |
Why?
|
Women's Health | 1 | 2019 | 2082 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3721 | 0.020 |
Why?
|
Cullin Proteins | 1 | 2009 | 180 | 0.020 |
Why?
|
Ubiquitins | 1 | 2009 | 366 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9384 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9613 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2012 | 977 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 4528 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18412 | 0.010 |
Why?
|
Phenotype | 1 | 2022 | 16726 | 0.010 |
Why?
|
Guinea Pigs | 1 | 2005 | 1310 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2005 | 660 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9523 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8647 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4887 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2005 | 1989 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 13053 | 0.010 |
Why?
|
DNA Primers | 1 | 2005 | 2828 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 2393 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10873 | 0.010 |
Why?
|
Eosinophils | 1 | 2005 | 952 | 0.010 |
Why?
|
Thymus Gland | 1 | 2005 | 1266 | 0.010 |
Why?
|
Animals | 4 | 2018 | 169246 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2005 | 4168 | 0.010 |
Why?
|
Spleen | 1 | 2005 | 2295 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24315 | 0.010 |
Why?
|
Mice | 2 | 2018 | 82029 | 0.010 |
Why?
|
Child | 1 | 2024 | 80917 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 12421 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2005 | 3474 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 19015 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 17140 | 0.010 |
Why?
|
Calcium | 1 | 2005 | 5792 | 0.010 |
Why?
|
Cell Line | 1 | 2005 | 15597 | 0.010 |
Why?
|
Lung | 1 | 2005 | 10099 | 0.000 |
Why?
|